Paolo Grassi
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer.
Journal: Cancer discovery
Published: May 14, 2025
Prospective Translational Study Investigating Molecular PrEdictors of Resistance to First-Line PazopanIb in Metastatic reNal CEll Carcinoma (PIPELINE Study).
Journal: American journal of clinical oncology
Published: September 05, 2020
TARIBO trial: targeted therapy with or without nephrectomy in metastatic renal cell carcinoma: liquid biopsy for biomarkers discovery.
Journal: Tumori
Published: December 02, 2017
Exposure to Multiple Lines of Treatment and Survival of Patients With Metastatic Renal Cell Carcinoma: A Real-world Analysis.
Journal: Clinical genitourinary cancer
Published: November 17, 2017
Multimodal treatment of advanced renal cancer in 2017.
Journal: Expert review of clinical pharmacology
Published: September 29, 2017
Castration-naive metastatic prostate cancer: reshaping old paradigms.
Journal: Expert review of anticancer therapy
Published: September 01, 2017
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?
Journal: Drugs in R&D
Published: August 13, 2017
Everolimus treatment for neuroendocrine tumors: latest results and clinical potential.
Journal: Therapeutic advances in medical oncology
Published: March 28, 2017
What advances have been made in immune-therapy for renal cell carcinoma?
Journal: Future oncology (London, England)
Published: February 11, 2017
Cabozantinib in advanced renal cell carcinoma: a METEOR impact on clinical practice.
Journal: Translational andrology and urology
Published: January 13, 2017
Last Updated: 09/26/2026